We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Sam Boal/
vaccine rollout

Vaccine registration is now open for 44 year olds

The vaccine registration portal will open for 43 to 40 year olds in the coming days.

PEOPLE AGED 44 can from today register for a Covid-19 vaccine, with registration opening for 43 to 40 year olds later in the week.

If you’re aged 44, you can now go to the HSE’s vaccination portal and register to get the jab – you’ll need a mobile phone number, an email address, your PPS number and your Eircode.

You can find your Eircode here. Your PPS number can be found on payslips, public services cards, medical or GP visit cards, European Health Insurance Cards (EHIC), Drugs Payment Scheme cards or letters from the Department of Social Protection or the Revenue Commission.

43 year olds can register from tomorrow, Thursday 3 June; 42 year olds can register from Friday and 41 and 40 year olds can register from Saturday and Sunday respectively.

People who are over 44 and haven’t registered for a vaccine yet can still do so through the HSE vaccine site. Everyone who registers will receive a text with details of your vaccination three to seven days before the appointment.

Over 1.4 million people in Ireland have now received one dose of the Covid-19 vaccine. Some 515,000 people have received two doses.

The rollout comes as Ireland is expected to receive extra Pfizer Covid-19 vaccines, after the European Medicines Agency (EMA) announced it has approved extra manufacturing of the jab.

The EMA confirmed yesterday that it has recommended the approval of additional manufacturing and filling lines at Pfizer’s vaccine manufacturing site in Puurs, Belgium.

The EMA said the recommendation by its Committee for Human Medicines is expected to have “a significant and immediate impact” on the supply of Comirnaty, the vaccine developed by Pfizer and BioNTech, in the European Union.


Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Your Voice
Readers Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel